BlackRock's position in Johnson & Johnson is currently worth $55B. That's 0.85% of their equity portfolio (15th largest holding). The investor owns 8.89% of the outstanding Johnson & Johnson stock. The first Johnson & Johnson trade was made in Q4 2020. Since then BlackRock bought shares twelve more times and sold shares on five occasions. The stake costed the investor $32.5B, netting the investor a gain of 69% so far.
A share of Johnson and Johnson (NYSE: JNJ) paid $0.25 per quarter in dividends in 1999. That same share pays $1.34 per quarter in 2026. The stock price has m...
Johnson & Johnson (JNJ) closed at $263.4 in the latest trading session, marking a -1.44% move from the prior day.
FuelCell Energy (NASDAQ:FCEL) shares declined on Wednesday after the company priced an upsized public offering of common stock, raising concerns among...
IRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform.